Home >> Industry News >> Roche receives EUA for Elecsys Anti-SARS-CoV-2 S test

Roche receives EUA for Elecsys Anti-SARS-CoV-2 S test

image_pdfCreate PDF

The laboratory-based Elecsys Anti-SARS-CoV-2 S test provides a numerical result from 0.40 to 250 U/mL as well as a qualitative result. It runs on Roche’s Cobas e analyzers.

Roche will begin shipping the test to U.S. laboratories in the next week. LabCorp will be the first lab to offer the testing option in the United States.

CAP TODAY
X